Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACTA.L Regulatory News (ACTA)

  • There is currently no data for ACTA

Trading Update

5 Sep 2008 16:47

RNS Number : 8872C
Acta S.p.A.
05 September 2008
 



5 September 2008

Acta S.p.A. ("Acta" or the "Company")

Trading Update

Acta, the AIM-listed catalyst developer today provides the following trading update prior to its interim results, due to be announced on 24 September 2008.

Despite the continued political and macro-economic support for the renewable energy and cleantech sectors, and the promising technical and commercial progress that the Company continues to make with its major customers and partners, it has become clear in recent weeks that the deterioration in the global economic situation is leading to a marked short-term reduction in research and development investment by the major corporations with which Acta is engaged.

This reduction has manifested itself in delays to the Company's development contract with Sumitomo and a major Asian manufacturer, as well as cut-backs in the scope of this programme and the reallocation of funds away from long term research. The Board is encouraged that, despite the current environment, the contract is still expected to proceed to the next stage within this year, although it is now expected to be at a lower value in the short to medium term than previously envisaged. This will have a significant impact on Acta's revenues, amounting to an approximate halving in expected revenues in the year to 31 December 2008.

While the drivers behind the need for environmental technologies remain acute, the Directors have determined that the impact of the current economic climate on Acta's customers will, therefore, reduce the value and timing of development contracts available to the Company over the medium term, and that this is likely to delay the commercialisation of Acta's products by one to two years, depending on the technology or application involved. 

The Company remains confident in its long term prospects, and this confidence is underpinned by the encouraging technical and commercial progress that the Company has made during the year to date, as announced in the business update of 17 July 2008. Acta is pursuing a number of promising initiatives, and the Company remains focused on developing commercial products and applications that have significant revenue earning potential over the long term.

Paolo Bert, Chief Executive, commented:

"Despite the revision to our immediate outlook, we are encouraged by the progress of our customer engagement and remain positive of our medium and longer term prospects, which are underpinned by the continued strong drivers for environmental technologies. The Company remains well funded, with sufficient resources to finance our activities until mid-2010. We are also implementing a prudent cost reduction programme to mitigate the reduction in expected revenues, to preserve funds and to focus our resources upon our commercial and technical programmes."

For further information, please contact:

Acta S.p.A:

Paul Barritt, Chief Financial Officer

Tel: +44 (0) 20 7360 4900

Smithfield Consultants:

George Hudson / Katie Hunt / Will Henderson

Tel: +44 (0) 20 7360 4900

Numis:

Tel: +44 (0) 20 7260 1000

Nominated advisor: Simon Blank / Lee Aston

Corporate Broking: David Poutney / Alex Ham

- Ends -

Notes to Editors

Acta S.p.A.

Acta develops and manufactures unique patented catalysts which have been launched initially to the renewable energy, automotive and portable electronics/battery markets. Acta is also developing other commercial opportunities using its catalysts for waste treatment in the bio-fuel, polymer and other industries.

Acta's catalysts for ammonia decomposition into hydrogen offer the automotive industry access to a practical hydrogen carrier for the first time. The catalysts extract hydrogen from ammonia at room temperature, allowing ammonia, one of the most widely used chemicals in the world, to become a fuel for automotive use, solving the problem of hydrogen storage and transportation.

Acta's catalyst range for alkaline membrane fuel cells allows fuel cell developers to stop using expensive platinum so that fuel cells can be made commercially viable for mass adoption, particularly in automotive and portable electronics applications. Adoption of Acta's HYPERMEC catalysts greatly reduces the cost of fuel cells and additionally allows for the first time the use of a wide range of safe liquid bio-fuels such as ethanol and glycerol.  

Simple passive alkaline membrane fuel cells can act as a high performance and environmentally friendly alternative to lead acid and alkaline batteries at a commercially acceptable price.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEELFBVKBZBBQ
Date   Source Headline
22nd Sep 20107:00 amRNSInterim Results
4th Aug 20107:01 amRNS2.7 MW Photovoltaic Project Consents Received
20th Jul 20107:01 amRNSService Station Agreement
20th Jul 20107:00 amRNSChange of Adviser
13th Jul 20105:19 pmRNSTR-1: Notification of Major Interest in Shares
13th Jul 20107:00 amRNSPositive Response to New Italian Feed-in-Tariff
1st Jul 20105:53 pmRNSIssue of Equity
1st Jul 201012:16 pmRNSActa exhibits at Goodwood Festival of Speed
29th Jun 20107:00 amRNSResult of AGM & marketing update
10th Jun 201010:52 amRNSActa unveils world's first hydrogen-powered tender
9th Jun 20108:00 amRNSChange of web site address
2nd Jun 20107:15 amRNSAnnual Financial Report
2nd Jun 20107:00 amRNSRe Contract
28th Apr 20107:00 amRNSAward of grant
22nd Apr 20107:00 amRNSHydrogen fuel enrichment test results
26th Mar 20105:05 pmRNSDirector/PDMR Shareholding
25th Mar 20107:00 amRNSPreliminary Results
23rd Mar 20107:00 amRNSPhotovoltaics Programme
3rd Mar 20107:00 amRNSSumitomo Corporation Distribution Agreement
15th Feb 20107:00 amRNSHydrogen Generator wins Qualitec Technology Award
2nd Feb 20107:00 amRNSTrading Update
20th Jan 20107:00 amRNSDirector/PDMR Shareholding
10th Dec 20098:50 amRNSTrade Show & Product Launch Update
25th Nov 20097:00 amRNSDevelopment Contract
22nd Oct 20097:00 amRNSProduct Launch Confirmation
24th Sep 20097:00 amRNSHalf Yearly Report
23rd Sep 20099:55 amRNSNotice of Forthcoming Interim Results Statement
10th Aug 20097:00 amRNSProduct Launch Update
22nd Jul 200912:08 pmRNSStatement re price movement
17th Jul 20097:00 amRNSTrading Update
25th Jun 20095:16 pmRNSResult of AGM
1st Jun 20097:00 amRNSPosting of Annual Report
28th May 20097:00 amRNSGrant of Options
26th Mar 20097:00 amRNSFinal Results
29th Jan 200910:39 amRNSDirectorate Change
26th Jan 20097:00 amRNSGrant Approval
22nd Jan 20097:00 amRNSTrading Statement
21st Jan 20092:06 pmRNSDirector Declaration
19th Jan 20097:00 amRNSChange of Adviser
7th Nov 20087:00 amRNSRe Contract
13th Oct 20081:11 pmRNSDirector/PDMR Shareholding
1st Oct 20087:00 amRNSDirector/PDMR Shareholding
24th Sep 20087:00 amRNSInterim Results
5th Sep 20084:47 pmRNSTrading Update
3rd Sep 20087:00 amRNSNotice of Results
23rd Jul 20087:00 amRNSCatalyst Launch Programme
17th Jul 20087:00 amRNSTrading Statement
23rd Jun 20087:00 amRNSDirectorate Change
10th Jun 20087:00 amRNSAGM Statement
30th Apr 20087:00 amRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.